Literature DB >> 2853167

Determination of 2',3'-dideoxyadenosine, 2',3'-dideoxyinosine and 2',3'-dideoxycytidine in biological samples.

J R Kalin1, D L Hill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2853167     DOI： 10.1016/s0378-4347(00)83083-2

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  5 in total

1.  Zalcitabine population pharmacokinetics: application of radioimmunoassay.

Authors:  J M Adams; M J Shelton; R G Hewitt; M DeRemer; R DiFrancesco; T H Grasela; G D Morse
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

2.  Toxicity and efficacy of 2',3'-dideoxycytidine in clinical trials of pigtailed macaques infected with simian retrovirus type 2.

Authors:  C C Tsai; K E Follis; M Yarnall; G A Blakley
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 3.  Zalcitabine. Clinical pharmacokinetics and efficacy.

Authors:  D Devineni; J M Gallo
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

4.  Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluid.

Authors:  D M Burger; H Rosing; C H ten Napel; T Duyts; P L Meenhorst; J W Mulder; C H Koks; A Bult; J H Beijnen
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

Review 5.  Didanosine, a new antiretroviral drug. A review.

Authors:  R M Franssen; P L Meenhorst; C H Koks; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.